FcγRIIa Polymorphism and Anti-Malaria-Specific IgG and IgG Subclass Responses in Populations Differing in Susceptibility to Malaria in Burkina Faso

Scandinavian Journal of Immunology

Volumn 75, Issue 6, 2012, Pages 606-613

  Cherif, M K ^a,b   Sanou, G S ^a,c   Maiga, B ^d   Israelsson, E ^e   Ouedraogo A L ^a   Bougouma, E C ^a   Diarra, A ^a   Ouedraogo A ^a   Ouattara, A S ^b   Troye Blomberg, M ^e   Dolo, A ^d   Cavanagh, D R ^f   Theisen, M ^g   Modiano, D ^h   Sirima, S B ^a   Nebie I ^a  

^a Burkina Faso   (Burkina Faso)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^c Polytechnic University of Bobo Dioulasso   (Burkina Faso)

^d University of Mali   (Mali)

^e STOCKHOLM UNIVERSITY   (Sweden)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g Department of Clinical Biochemistry Statens Serum ^*  (Denmark)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR IIA; GLUTAMATE RICH PROTEIN R0; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 2; MEROZOITE SURFACE PROTEIN 2A; MEROZOITE SURFACE PROTEIN 2B; MEROZOITE SURFACE PROTEIN 3; PARASITE ANTIGEN; PLASMODIUM FALCIPARUM 10; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIBODY RESPONSE; ARTICLE; BURKINA FASO; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BURKINA FASO; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG;

EID: 84861464338     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02690.x     Document Type: Article

References (38)

1. Cohen S, Mc GI, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961;192:733-7.
2. Sabchareon A, Burnouf T, Ouattara D et al. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 1991;45:297-308.
3. Pleass RJ, Woof JM. Fc receptors and immunity to parasites. Trends Parasitol 2001;17:545-51.
4. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990;172:1633-41.
5. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 1995;182:409-18.
6. Ferrante A, Kumaratilake L, Rzepczyk CM, Dayer JM. Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages). Immunol Lett 1990;25:179-87.
7. Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, Druilhe PL. A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol 2007;178:3099-106.
8. Tebo AE, Kremsner PG, Luty AJF. Plasmodium falciparum: a major role for IgG3 in antibody- dependent monocyte-mediated cellular inhibition of parasite growth in vitro. Exp Parasitol 2001;98:20.
9. Tebo AE, Kremsner PG, Luty AJ. Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. Clin Exp Immunol 2002;130:300.
10. Ouma C, Keller CC, Opondo DA et al. Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children. Am J Trop Med Hyg 2006;74:573-7.
11. Aribot G, Rogier C, Sarthou JL et al. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, West Africa). Am J Trop Med Hyg 1996;54:449-57.
12. Clark MR, Clarkson SB, Ory PA, Stollman N, Goldstein IM. Molecular basis for a polymorphism involving Fc receptor II on human monocytes. J Immunol 1989;143:1731-4.
13. Clark MR, Stuart SG, Kimberly RP, Ory PA, Goldstein IM. A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes. Eur J Immunol 1991;21:1911-6.
14. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 1991;147:1338-43.
15. Aucan C, Traore Y, Tall F et al. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect Immun 2000;68:1252-8.
16. Leoratti FM, Durlacher RR, Lacerda MV et al. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Malar J 2008;7:186.
17. Nasr A, Iriemenam NC, Troye-Blomberg M et al. Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients. Scand J Immunol 2007;66:87-96.
18. Sinha SMS, Sharma S, Patibandla PK et al. Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 2008;7:13.
19. Dolo A, Modiano D, Maiga B et al. Difference in susceptibility to malaria between two sympatric ethnic groups in Mali. Am J Trop Med Hyg 2005;72:243-8.
20. Modiano D, Petrarca V, Sirima BS et al. Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc Natl Acad Sci U S A 1996;93:13206-11.
21. Greenwood BM, Groenendaal F, Bradley AK et al. Ethnic differences in the prevalence of splenomegaly and malaria in The Gambia. Ann Trop Med Parasitol 1987;81:345-54.
22. Pandey JP, Nasr A, Rocca KM, Troy-Blomberg M, Elghazali G. Significant differences in GM allotype frequencies between two sympatric tribes with markedly differential susceptibility to malaria. Parasite Immunol 2007;29:267-9.
23. Modiano D, Petrarca V, Sirima BS et al. Plasmodium falciparum malaria in sympatric ethnic groups of Burkina Faso, west Africa. Parassitologia 1995;37:255-9.
24. Bolad A, Farouk SE, Israelsson E et al. Distinct interethnic differences in immunoglobulin G class/subclass and immunoglobulin M antibody responses to malaria antigens but not in immunoglobulin G responses to nonmalarial antigens in sympatric tribes living in West Africa. Scand J Immunol 2005;61:380-6.
25. Israelsson E, Vafa M, Maiga B et al. Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali. Malar J 2008;7:175.
26. Nasr A, Iriemenam NC, Giha HA et al. FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan. Malar J 2009;8:43.
27. Hamad AA, Nugud Ael H, Arnot DE et al. A marked seasonality of malaria transmission in two rural sites in eastern Sudan. Acta Trop 2002;83:71-82.
28. Creasey A, Giha H, Hamad AA, El Hassan IM, Theander TG, Arnot DE. Eleven years of malaria surveillance in a Sudanese village highlights unexpected variation in individual disease susceptibility and outbreak severity. Parasitology 2004;129:263-71.
29. Giha HA, Staalsoe T, Dodoo D et al. Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes. Infect Immun 1999;67:4092-8.
30. Nebie I, Diarra A, Ouedraogo A et al. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun 2008;76:759-66.
31. Sirima SB, Tiono AB, Ouedraogo A et al. Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24months-old Burkinabe children. PLoS ONE 2009;4:e7549.
32. Polley SD, Conway DJ, Cavanagh DR et al. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 2006;24:4233-46.
33. Borre MB, Dziegiel M, Hogh B et al. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol 1991;49:119-31.
34. Daniel Dodoo AA, Kusi KA, Lamptey H et al. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J 2008;7:142.
35. Harwaldt P, Rahlfs S, Becker K. Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target. Biol Chem 2002;383:821-30.
36. Nebie I, Cuzin-Ouattara N, Diallo DA et al. Humoral responses to defined malaria antigens in children living since birth under insecticide treated curtains in Burkina Faso. Acta Trop 2003;88:17-25.
37. Modiano D, Chiucchiuini A, Petrarca V et al. Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein. Am J Trop Med Hyg 1999;61:663-7.
38. Cooke GS, Aucan C, Walley AJ et al. Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg 2003;69:565-8.